FRANKLIN LAKES, N.J.,
Sept. 29, 2017 /PRNewswire/ -- BD
(Becton, Dickinson and Company) (NYSE: BDX), a leading global
medical technology company, today announced that two current
directors of C.R. Bard, Inc. will join the BD board of directors
following the completion of BD's pending acquisition of Bard.
Timothy M. Ring, chairman and CEO
of Bard, and David F. Melcher,
president and CEO of the Aerospace Industries Association, have
been elected to the two newly created seats on the BD board of
directors, in accordance with the acquisition agreement.
Mr. Ring has served as chairman and CEO of Bard since
Aug. 8, 2003. He joined Bard in
June 1992 and has served in many
leadership roles including corporate vice president of Human
Resources, group vice president of Bard International, group
president for Coronary Vascular Products and group president for
Electrophysiology and Peripheral Vascular Products. Prior to
joining Bard, Mr. Ring worked for Abbott Laboratories and The
General Motors Corporation.
In addition to the Bard board of directors, Mr. Ring is a
director of Quest Diagnostics Incorporated, a trustee for the New
Jersey Health Foundation (NJHF), and a board member for the
Advanced Medical Technology Association (AdvaMed), the National
Association of Manufacturers (NAM) and the Healthcare Leadership
Council. He also currently serves on the Cornell University Council and is a former Chairman
of the Board of Trustees of the HealthCare Institute of
New Jersey (HINJ).
Mr. Ring earned a bachelor of science degree in Industrial and
Labor Relations from Cornell
University.
David F. Melcher has been
president and CEO of the Aerospace Industries Association (AIA)
since 2015. Prior to AIA, Mr. Melcher was CEO and president of
Exelis Inc., a spinoff of ITT Corporation. Mr. Melcher joined ITT
in 2008 after a 32-year career with the U.S. Army until his
retirement as a Lieutenant General.
In addition to being a director for Bard, Mr. Melcher is a
member of the Federal Aviation Administration's NextGen Advisory
Committee, providing advice on policy-level issues for the nation's
aviation modernization. He is a recipient of the Army's
Distinguished Service Medal and the Association of the U.S. Army
John W. Dixon award for contributions to the defense industry.
Mr. Melcher holds a bachelor of science degree in civil
engineering from the U.S. Military Academy at
West Point and two master's degrees, one in business
administration from Harvard University
and the other in public administration from Shippensburg University.
About BD
BD is a global medical technology company that is advancing the
world of health by improving medical discovery, diagnostics and
the delivery of care. BD leads in patient and health care worker
safety and the technologies that enable medical research and
clinical laboratories. The company provides innovative solutions
that help advance medical research and genomics, enhance the
diagnosis of infectious disease and cancer, improve medication
management, promote infection prevention, equip surgical and
interventional procedures, and support the management of diabetes.
The company partners with organizations around the world to address
some of the most challenging global health issues. BD has nearly
50,000 associates across 50 countries who work in close
collaboration with customers and partners to help enhance outcomes,
lower health care delivery costs, increase efficiencies, improve
health care safety and expand access to health. For more
information on BD, please visit bd.com.
View original
content:http://www.prnewswire.com/news-releases/timothy-m-ring-and-david-f-melcher-to-join-bd-board-of-directors-300528308.html
SOURCE BD